Indivior Chief Scientific Officer Sells 18,586 Shares Amid Bullish 161% YTD Surge, Routine Plan Execution Confirms Confidence
Indivior insider sale by CSO Christian Heidbreder shows routine 10‑b‑5 trading amid a 161% YTD rally, confirming confidence in future clinical gains.
- INDIVIOR PHARMACEUTICALS INC
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read

